Metraipolis › archive › dc_32987100cbae

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase… — Europe PMC PMID:41393919

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41393919
DOI
10.1155/arat/8818830
License (as archived)
solo-consultazione
Archived
2026-11-07T16:44:40.792Z
SHA-256 of the archived text
a8aa6723cac6535c2db84f00bc128ed8875d8c8879af10cb790912de9edd3df5
Stable URL of this page
https://metraipolis.com/documento/dc_32987100cbae

How to cite

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase… — Europe PMC PMID:41393919 — Europe PMC (en), https://europepmc.org/article/MED/41393919 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32987100cbae (Metraipolis archive dc_32987100cbae, sha256 a8aa6723cac6535c2db84f00bc128ed8875d8c8879af10cb790912de9edd3df5)
BibTeX
@misc{dc32987100cbae,
  title = {BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase… — Europe PMC PMID:41393919},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41393919},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32987100cbae; sha256 a8aa6723cac6535c2db84f00bc128ed8875d8c8879af10cb790912de9edd3df5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41393919. Agents can read the archived copy with the MCP tool read_document.